期刊文献+

hTERT蛋白在贲门癌及癌旁组织中表达的临床意义 被引量:1

The Clinical Significance of hTERT Protein Expression in Cardiac Carcinoma and Paracancerous Tissues
下载PDF
导出
摘要 目的探讨hTERT蛋白在贲门癌及癌旁组织中表达的临床意义。方法采用免疫组化MaxvisionTM法,检测98例贲门癌及癌旁组织中hTERT蛋白的表达情况。结果hTERT蛋白表达阳性率与贲门癌病理组织学类型、组织分级及肿瘤大小无关,与肿瘤浸润深度、淋巴结转移情况、PTNM分期相关。hTERT蛋白在癌旁组织中表达情况与患者2、3年吻合口复发率密切相关。结论hTERT蛋白表达预示贲门癌具有较强的侵袭转移能力,可作为预测贲门癌转移潜能和预后的生物学指标之一,对手术范围的合理选择和临床早期干预治疗具有重要指导意义。 Objective To study the clinical significance of the expression of hTERT protein in cardiac carcinoma and paracaneerous tissues. Methods The expression of hTERT protein was detected with MaxvisionTM immunohistochemical method in the cancerous and para - cancerous tissues from 98 patients with cardiac carcinoma. Results Expression of hTERT protein was significantly correlated with the invasion depth,lymph node metastasis and pTNM stage. There were no significant correlation between the positive expression of hTERT protein and tumor size, pathological differentiation, pathological types, pathological grade. Expression of hTERT in the paraeancerous tissues was significantly correlated with the 2 and 3 year recurrent rates in the anastomotic regions. Conclusion Expression of hTERT protein might predict the metastatic potential in cardiac carcinoma. Detection of the hTERT expression may be useful in determining the surgical extent and adjuvant treatment in patients with cardiac carcinoma.
机构地区 江西省肿瘤医院
出处 《实用癌症杂志》 2009年第1期26-28,共3页 The Practical Journal of Cancer
关键词 贲门癌 HTERT蛋白 Cardiac carcinoma hTERT protein
  • 相关文献

参考文献8

  • 1徐大志,詹友庆,吴秋良,赖英荣,李威,陈映波,孙晓卫,徐立,关远祥,李元方.胃癌胃壁浸润长度的大切片研究[J].癌症,2005,24(6):707-710. 被引量:7
  • 2Chung HK, Cheong C, Song J, et al. Extratelomeric functions of telomerase[ J]. Cnrr Mol Med,2005,5 (2) :233.
  • 3Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells:how can we apply them for cancer therapy[ J]. Oncogene,2002,21 (4) :688.
  • 4Gu J, Andreeff M, Roth JA, et al. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity[ J]. Gene Ther,2002,9 ( 1 ) :30.
  • 5齐洁敏,白兴武,白联宏.HP、hTERT在胃癌及癌前病变中的表达及相关性研究[J].陕西医学杂志,2008,37(1):32-35. 被引量:6
  • 6钟英强,沈溪明,李海刚,曾志勇,刘娟,朱兆华.hTERT在人胰腺癌组织中的表达及其与COX-2、P-gp、Bcl-2蛋白表达和临床病理特征的关系[J].中华临床医师杂志(电子版),2008,2(8):14-18. 被引量:12
  • 7Ono C, Yoshinaga K, Enomoto M, et al. Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ [ J]. Dis Colon Rectum, 2002,45 (6) :744.
  • 8Nakagoe T, Yamaguchi E, Tanaka K, et al. Distal intramural spread is an independentprognostic factor for distant metastasis and poor outcome in patients with rectal cancer: a multivariate analysis [ J ]. Ann Surg Oncol, 2003,10 (2) : 163.

二级参考文献38

  • 1李莉,熊永炎,刘琳,陈桃香,姚兴凤,汪燕舞.非小细胞肺癌组织中hTERT、MDR1和MRPmRNA与C-myc蛋白的表达及相关性研究[J].癌症,2005,24(1):53-57. 被引量:9
  • 2钟英强,李海刚,曾志勇.胰腺癌组织端粒酶逆转录酶的表达及其与临床病理的关系[J].临床消化病杂志,2005,17(2):65-66. 被引量:5
  • 3刘立玺,石巍,廖爱军,文剑波,文平.尼美舒利对人SGC-7901细胞系增殖及hTERT-mRNA表达的研究[J].实用癌症杂志,2006,21(1):7-10. 被引量:1
  • 4Seeliger H, Spatz H, Jauch KW. Minimal residual disease in gastric cancer [J]. Recent Results Cancer Res, 2003,162:79-87.
  • 5陈峻青.胃癌外科治疗的“老问题”与新进展[C]..2000年全国肿瘤学术大会论文集[C].北京:科学出版社,2000.644-650.
  • 6Yamauchi M, Idota C, Kondo K, et al. Determination of the oral side safety margin in the resection of a Borrmann 4 type gastric cancer [J]. Gan No Rinsho, 1990,36(6):700-703.
  • 7Fujimoto S, Takashi M, Mutou T, et al. Clinicopathologic characteristics of gastric cancer patients with cancer infiltration at surgical margin at gastrectomy [J]. Anticancer Res, 1997,17 (1B): 689-694.
  • 8Gall GP, Hermanek P. New aspects in the surgical treatment of gastric carcinoma-a comparative study of 1636 patients operated on between 1969 and 1982 [J]. Eur J Surg Oncol,1985,11(3) :219-225.
  • 9Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial [J]. Ann Surg, 1999,230(2): 170-178.
  • 10Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3total gastrectomy for antral cancer [J]. Ann Surg, 1994,220(2): 176-182.

共引文献22

同被引文献19

  • 1王德利.腺病毒载体的研究进展[J].海军总医院学报,2004,17(4):227-230. 被引量:6
  • 2刘丹,陶泽璋,肖伯奎,陈始明,池花明.短发夹RNA沉默hTERT基因对人喉癌裸鼠移植瘤的生长抑制作用[J].癌症,2006,25(1):11-16. 被引量:12
  • 3Ito H,Kanzawa T,Miyoshi T,et al.Therapeutic efficacy of PU-MA for malignant glioma cells regardless of p53 status[J].HumGene Ther,2005,16(6):685-698.
  • 4Count ER,Hi RT,Bacchet TI,et al.Telomerase activity in hu-man ovarian carcinoma[J].Proc Natl Acad Sci U S A,1994,91(8):2900-2904.
  • 5Frías C,Morán A,de Juan C,et al.Telomere function in colorec-tal cancer[J].World J Gastrointest Oncol,2009,1(1):3-11.
  • 6Malaska J,Kunicka Z,Borsky M,et al.Telomerase as a diagnos-tic and predictive marker in colorectal carcinoma[J].Neoplasma,2004,51(2):90-96.
  • 7Woo HJ,Choi YH.Growth inhabition of A549 human lung carcino-ma cells by beta lapachone through induction of apoptosis and inha-bition of telomerase activity[J].Int J Oncol,2005,26(4):1017-1023.
  • 8Song MS,Jeong JS,Cho KS,et al.Gene expression responses invivo by human telomerase reverse transcriptase(hTERT)-targetingtrans-splicing ribozyme[J].Exp Mol Med,2007,39(6):722-732.
  • 9Dorsett Y,Tuschl T.siRNAs:Applications in functional genomicsand potential as therapeutics[J].Nat Rev Drug Discov,2004,3(4):318-329.
  • 10Frederik HE,Harm CA,Graat JE,et al.Replacement of nativeadenovirus receptor-binding sites with a new attachment moiety di-minishes hepatic tropism and enhances bioavailability in mice[J].Hum Gene Ther,2008,19(8):783-794.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部